News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Junshi Biosciences Announces European Commission Approval for Marketing of Toripalimab
Wednesday, September 25, 2024Shanghai Junshi Biosciences Co Ltd a leading innovationdriven biopharmaceutical company dedicated to the discovery development and commercialization of novel therapies and its whollyowned subsidiary TopAlliance Biosciences Inc TopAlliance Biosciences...
Araris Biotech AG Expands its IP Portfolio with the Acquisition of Innate Pharma’s Portfolio of Transglutaminase Patents for the Generation of Antibody-Drug Conjugates (ADCs)
Wednesday, September 25, 2024Araris Biotech AG a Swiss oncology biotech company developing nextgeneration antibodydrug conjugates ADCs today announced it has entered into an Agreement with Innate Pharma Innate Under the agreement Innate will assign its portfolio of patents
QIAGEN and Bode Technology partner to advance use of GEDmatch PRO forensic genetic genealogy database
Tuesday, September 24, 2024QIAGEN NV announced that Bode Technology the largest private US forensics laboratory company with a growing presence in other regions would become the exclusive global commercial partner for the GEDmatch PRO genealogy database
DBV Technologies Completes Screening for the VITESSE Phase 3 Clinical Trial
Tuesday, September 24, 2024DBV Technologies a clinicalstage biopharmaceutical company today announced that patient screening is complete for the Phase trial VITESSE Viaskin Peanut Immunotherapy Trial to Evaluate Safety Simplicity and Efficacy using the modified
Agarose Bead Technologies expands facility to meet rising global demand for novel therapies market
Tuesday, September 24, 2024Agarose Bead Technologies ABT a leading manufacturer of highquality agarose resins proudly announces the completion of a major expansion at its facility located in Northern Spain Burgos The sqm addition positions ABT as one of Europes largest manufa...
Agilent Completes Acquisition of BIOVECTRA
Monday, September 23, 2024Agilent Technologies Inc announced the company has completed its acquisition of BIOVECTRA a Canadabased contract development and manufacturing organization CDMO that specializes in biologics highly potent active pharmaceutical ingredients
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European Union
Monday, September 23, 2024Pfizer Inc and BioNTech SE announced that the Committee for Medicinal Products for Human Use CHMP of the European Medicines Agency EMA has recommended marketing authorization for the companies Omicron KPadapted monovalent COVID vaccine
Bavarian Nordic Receives EMA Approval of Mpox Vaccine for Adolescents
Friday, September 20, 2024Bavarian Nordic AS announced today that the European Commission has adopted the Committee for Medicinal Products for Human Use CHMP recommendation for the approval of a type II variation for IMVANEX MVABN smallpox and mpox vaccine
Axcelead Drug Discovery Partners Enters into Master Service Agreement for Drug Discovery Projects with Acadia Pharmaceuticals
Friday, September 20, 2024Axcelead Drug Discovery Partners Inc announced on September that it had entered into a Master Service Agreement with Acadia Pharmaceuticals Inc to support their goal of discovering and developing innovative and novel medicines
QIAGEN expands QIAcuity digital PCR offering with over new 100 assays via GeneGlobe platform
Thursday, September 19, 2024QIAGEN announced an important milestone with the launch of new assays for its digital PCR dPCR platform QIAcuity for use in the study of cancer inherited genetic disorders infectious disease surveillance and food and environmental monitoring
